Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Effect of donation time on platelet concentrates and fresh-frozen plasma. An in vitro study.

Huh YO, Lichtiger B, Giacco GG, Guinee VF, Drewinko B.

Vox Sang. 1989;56(1):21-4.

PMID:
2492698
3.

Flow cytochemical patterns of white blood cells in human hematopoietic malignancies: III. Miscellaneous hemopoietic diseases.

Drewinko B, Bollinger P, Brailas C, Wyatt J, Simson E, Trujillo JM.

Blood Cells. 1988;13(3):475-86.

PMID:
3382753
4.
5.

Failure of human myeloma cells to heterotransplant into the brain of athymic rats.

Drewinko B, Moskwa PS.

Anticancer Res. 1987 Nov-Dec;7(6):1143-7.

PMID:
3442413
6.

Flow cytochemical patterns of white blood cells in human haematopoietic malignancies. II. Chronic leukaemias.

Drewinko B, Bollinger P, Brailas C, Wyatt J, Simson E, Trujillo JM.

Br J Haematol. 1987 Oct;67(2):157-65.

PMID:
3479189
7.

Untreated prostatic carcinoma is not associated with frequent thrombohemorrhagic disorders.

Drewinko B, Cobb P, Guinee V, Giacco G, Trujillo JM, von Eschenbach A.

Urology. 1987 Jul;30(1):11-7.

PMID:
3603903
8.

Flow cytochemical patterns of white blood cells in human haematopoietic malignancies. I. Acute leukaemias.

Drewinko B, Bollinger P, Brailas C, Moyle S, Wyatt J, Simson E, Johnston D, Trujillo JM.

Br J Haematol. 1987 May;66(1):27-36.

PMID:
3593655
9.

Evaluation of growth fractions with monoclonal antibodies to human alpha-DNA polymerase.

Alama A, Nicolin A, Conte PF, Drewinko B.

Cancer Res. 1987 Apr 1;47(7):1892-6.

10.

Expression of transferrin receptors is unrelated to proliferative status in cultured human colon cancer cells.

Drewinko B, Moskwa P, Reuben J.

Anticancer Res. 1987 Mar-Apr;7(2):139-41.

PMID:
3592625
11.

The technicon H*1--an automated hematology analyzer for today and tomorrow. Complete blood count parameters.

Bollinger PB, Drewinko B, Brailas CD, Smeeton NA, Trujillo JM.

Am J Clin Pathol. 1987 Jan;87(1):71-8.

PMID:
3799545
12.
14.

In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.

Ajani JA, Spitzer G, Tomasovic B, Drewinko B, Hug VM, Dicke K.

Br J Cancer. 1986 Oct;54(4):607-13.

15.

New monoclonal antibodies against colon cancer-associated antigens.

Drewinko B, Yang LY, Chan J, Trujillo JM.

Cancer Res. 1986 Oct;46(10):5137-43.

16.

Potential drugs for elimination of acute lymphatic leukemia cells from autologous bone marrow.

Blaauw A, Spitzer G, Dicke K, Drewinko B, Vellekoop L, Zander A.

Exp Hematol. 1986 Aug;14(7):683-8.

PMID:
2426131
17.

Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center.

Pinzon R, Drewinko B, Trujillo JM, Guinee V, Giacco G.

J Clin Oncol. 1986 Apr;4(4):509-14.

PMID:
3958764
18.

Phase I study of thymidine (dThd) and cisplatin (DDP) given in combination.

Chiuten DF, Valdivieso M, Benvenuto JA, Drewinko B, Bedikian A, Bodey GP.

Am J Clin Oncol. 1986 Apr;9(2):129-31.

PMID:
3717079
20.

Mathematical model for human myeloma relating growth kinetics and drug resistance.

Hokanson JA, Brown BW, Thompson JR, Jansson B, Drewinko B.

Cell Tissue Kinet. 1986 Jan;19(1):1-10.

PMID:
3955625
21.

Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate.

Umbach GE, Spitzer G, Ajani JA, Hug V, Thames H, Rudolph FB, Drewinko B.

J Cancer Res Clin Oncol. 1986;111(3):273-6.

PMID:
3733857
23.

The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitro.

Drewinko B, Yang LY.

Invest New Drugs. 1986;4(4):289-93.

PMID:
3583640
24.

Peplomycin and bleomycin effects on human colon cancer cells.

Uematsu A, Ho DH, Drewinko B, Yang LY, Brown NS, Bodey GP, Krakoff IH.

Anticancer Res. 1986 Jan-Feb;6(1):1-3.

PMID:
2420264
25.

Estrogen induced expansion of the growth fraction in receptor negative human breast cancer.

Conte PF, Fraschini G, Drewinko B.

J Steroid Biochem. 1985 Dec;23(6B):1169-72.

PMID:
4094431
26.

Cellular basis for the inefficacy of 5-FU in human colon carcinoma.

Drewinko B, Yang LY.

Cancer Treat Rep. 1985 Dec;69(12):1391-8.

PMID:
4075316
27.

Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.

Hug V, Hortobagyi GN, Drewinko B, Finders M.

J Clin Oncol. 1985 Dec;3(12):1672-7.

PMID:
4067614
28.

Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer.

Conte PF, Fraschini G, Alama A, Nicolin A, Corsaro E, Canavese G, Rosso R, Drewinko B.

Cancer Res. 1985 Nov;45(11 Pt 2):5926-30.

29.
30.

Effects and interactions of epidermal growth factor, insulin, hydrocortisone, and estradiol on the cloning of human tumor cells.

Singletary SE, Tomasovic B, Spitzer G, Tucker SL, Hug V, Drewinko B.

Int J Cell Cloning. 1985 Nov;3(6):407-14.

PMID:
3905997
31.

The synergistic lethal interaction of cis-diamminedichloroplatinum and natural nucleosides is related to increased DNA cross-links.

Drewinko B, Dipasquale MA, Yang LY, Barlogie B, Trujillo JM.

Chem Biol Interact. 1985 Oct;55(1-2):1-12.

PMID:
4064187
32.

Clinical evaluation of high-dose cytarabine and cisplatin in recurrent cervical carcinoma.

Keeney ED, Freedman RS, Drewinko B, Rutledge FN, Atkinson EN.

Cancer Treat Rep. 1985 Sep;69(9):1023-5. No abstract available.

PMID:
4040808
33.

Comparative sensitivity of different methods to detect and quantify circulating fibrinogen/fibrin split products.

Drewinko B, Surgeon J, Cobb P, Callahan L, Schmidt D, Bollinger P, Trujillo JM.

Am J Clin Pathol. 1985 Jul;84(1):58-66.

PMID:
3893094
34.

Growth kinetics of human colorectal carcinoma.

Ota DM, Drewinko B.

Cancer Res. 1985 May;45(5):2128-31.

35.

Cytotoxic efficacy of reconstituted and stored antitumor agents.

Yang LY, Drewinko B.

Cancer Res. 1985 Apr;45(4):1511-5.

37.

The human tumor stem cell assay revisited.

Singletary SE, Umbach GE, Spitzer G, Drewinko B, Tomasovic B, Ajani J, Hug V, Blumenschein G.

Int J Cell Cloning. 1985 Mar;3(2):116-28.

PMID:
3998518
38.

Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors.

Hug V, Drewinko B, Hortobagyi GN, Blumenschein G.

Breast Cancer Res Treat. 1985;6(3):237-40.

PMID:
4092099
39.

Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.

Umbach GE, Hug V, Spitzer G, Tomasovic B, Thames H, Ajani JA, Drewinko B.

J Cancer Res Clin Oncol. 1985;109(2):130-4.

PMID:
3980561
40.

Comparative cytotoxicity between cisplatin and second generation platinum analogs.

Drewinko B, Yang LY, Trujillo JM.

Invest New Drugs. 1985;3(4):335-40.

PMID:
3910609
41.

Medroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitro.

Umbach GE, Spitzer G, Drewinko B, Gercovich G, Hortobagyi G.

Breast Cancer Res Treat. 1985;5(1):87-9. No abstract available.

PMID:
3156645
42.

Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.

Umbach GE, Singletary SE, Tomasovic B, Spitzer G, Hug V, Drewinko B.

Int J Cell Cloning. 1984 Nov;2(6):335-40.

PMID:
6542929
43.

ARH-77, an established human IgG-producing myeloma cell line. II. Growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan.

Drewinko B, Mars W, Stragand JJ, Henderson SD, Latreille J, Barlogie B, Trujillo JM.

Cancer. 1984 Nov 1;54(9):1893-903.

PMID:
6236873
44.
45.

Cellular discriminants for a biological classification of human colon carcinoma.

Drewinko B, Yang LY, Leibovitz A, Barlogie B, Lutz D, Jansson B, Stragand JJ, Trujillo JM.

Cancer Res. 1984 Oct;44(10):4241-53.

47.
48.

Testing methotrexate sensitivity of human malignancies in the human tumour stem cell assay.

Umbach GE, Spitzer G, Drewinko B.

Clin Oncol. 1984 Jun;10(2):189-90. No abstract available.

PMID:
6734012
49.

Normalization of in vitro sensitivity testing of human tumor clonogenic cells.

Hug V, Thames H, Blumenschein GR, Spitzer G, Drewinko B.

Cancer Res. 1984 Mar;44(3):923-8.

50.

The true predictive value of the human tumor stem cell assay: does a workable assay select for treatment responders?

Hug V, Thames H, Johnston D, Blumenschein G, Drewinko B, Spitzer G.

J Clin Oncol. 1984 Jan;2(1):42-5.

PMID:
6699657

Supplemental Content

Loading ...
Support Center